Lundberg Sven Ante

Track

Insider profile

Lundberg Sven Ante's trades of Vor Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
17.45
Quantity 37,258
Value US$565,919
US Merus NV (MRUS)
Transaction date
Planned purchase
Price
201.95
Quantity 25,689 -39.7%
Value US$4,724,454
US Merus NV (MRUS)
Transaction date
Planned purchase
Price
294.38
Quantity 9,826 +8.6%
Value US$2,914,200
US Merus NV (MRUS)
Transaction date
Planned purchase
Price
22.99
Quantity 704 +3.6%
Value US$16,187
US Merus NV (MRUS)
Transaction date
Planned purchase
Price
22.97
Quantity 4,340 +28.9%
Value US$99,685
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-04 2025-08-04
PrS Proposed sale
37,258
17.45
US$565,919 		37,258 17.45 US$565,919
2022-11-03 2022-11-03
US Merus NV (MRUS)
PP Planned purchase
25,689 -39.7%
201.95
US$4,724,454 		25,689 -39.7% 201.95 US$4,724,454
2022-08-23 2022-08-22
US Merus NV (MRUS)
PP Planned purchase
9,826 +8.6%
294.38
US$2,914,200 		9,826 +8.6% 294.38 US$2,914,200
2022-08-22 2022-08-19
US Merus NV (MRUS)
PP Planned purchase
704 +3.6%
22.99
US$16,187 		704 +3.6% 22.99 US$16,187
2022-07-13 2022-07-12
US Merus NV (MRUS)
PP Planned purchase
4,340 +28.9%
22.97
US$99,685 		4,340 +28.9% 22.97 US$99,685